Hemodynamics, Salt Sensitivity and Body Composition in Patients With Morbid Obesity
1 other identifier
observational
36
1 country
1
Brief Summary
The purpose of this study is to evaluate the effect of high vs. low sodium intake on blood pressure and system hemodynamics in patients with morbid obesity and to evaluate the impact of laparoscopic gastric bypass on blood pressure, salt sensitivity and body composition in morbidly obese patients. Furthermore, we wants to describe the hemodynamic mechanisms involved in the amelioration of blood pressure during long-term weight loss.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2009
CompletedFirst Posted
Study publicly available on registry
October 20, 2009
CompletedStudy Start
First participant enrolled
November 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedMarch 20, 2013
March 1, 2013
3.1 years
October 19, 2009
March 19, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sodium induced change in 24-hour blood pressure before and one year after laparoscopic gastric bypass.
One year
Secondary Outcomes (4)
Echocardiography: Dimensions, systolic and diastolic function before and one year after laparoscopic gastric bypass
One year
Non-invasive hemodynamic measurements (inert gas rebreathing) before and one year after laparoscopic gastric bypass
One year
Body composition: Dexa-scan, plasma volume and extracellular volume before and one year after laparoscopic gastric bypass
One year
Blood samples: MR-proANP, p-glucose, p-insulin
One year
Study Arms (3)
Obese, hypertension
Obese patients with hypertension and a body mass index 40-50 kg/m2
Control
Control subjects without hypertension and body mass index \< 30 kg/m2
Obese, normotension
Obese patients without hypertension and a BMI between 40-50 kg/m2
Interventions
Blood pressure is measured every 15 minutes in the daytime and every 30 minutes at night
Standard 2-D and m-mode echocardiography with determination of dimensions, systolic, and diastolic function.
Cardiac output, stroke volume and total peripheral resistance are tested at rest and during exercise (bicycle ergometer) using non-invasive equipment (inert gas rebreathing - Innocor)
Fat mass and fat free mass is determined with a whole body Dexa scan, and bone mineral density is tested with Dexa-scans of the lumbar spine and proximal femur.
The test is performed using 5 MBq technetium-labeled albumine (99mTc-albumine - Vasculosis) with several postinjection samples for accurate zero-time extrapolation.
GFR and ECV are determined following injection of 3,7 MBq 51Cr-EDTA and postinjection samples three-four hours after injection.
p-glucose, p-insulin, NT-proBNP, hemoglobin, potassium, sodium, creatinine, albumine
24-hour urine collections with determination of u-sodium, u-potassium and u-creatinine.
Participants are subjected to 5 days of low (90 mmol/day) and high (250 mmol/day) sodium intake in a randomized order before and 1 year after laparoscopic gastric bypass surgery.
Eligibility Criteria
The cases are recruited from the Bariatric Clinics at Glostrup Hospital, Koege Hospital and The Private Hospital Hamlet. Controls are recruited through public advertisement
You may qualify if:
- Caucasians fulfilling the criteria for laparoscopic gastric bypass.
- participants with hypertension, defined as blood pressure \> 140/90 and/or use of antihypertensive medication and 12 participants without hypertension.
- Body mass index 40-50 kg/m2
- Caucasian.
- No hypertension or use of antihypertensive medication.
- Body mass index \< 30 kg/m2
You may not qualify if:
- Pregnancy
- Chronic obstructive pulmonary disease
- Diabetes mellitus
- Medical treatment with sibutramine.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Koege, Department of Clinical Physiology and Nuclear Medicine
Koege, DK-4600, Denmark
Related Publications (1)
Bonfils PK, Taskiran M, Damgaard M, Goetze JP, Floyd AK, Funch-Jensen P, Kristiansen VB, Stockel M, Bouchelouche PN, Gadsboll N. Roux-en-Y gastric bypass alleviates hypertension and is associated with an increase in mid-regional pro-atrial natriuretic peptide in morbid obese patients. J Hypertens. 2015 Jun;33(6):1215-25. doi: 10.1097/HJH.0000000000000526.
PMID: 25668345DERIVED
Biospecimen
Blood samples: p-glucose, p-insulin, MR-proANP, hemoglobine, sodium, potassium, creatinine, albumine. Urine collections: u-sodium, u-potassium, u-creatinine
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter K Bonfils, MD
University Hospital Koege
- STUDY DIRECTOR
Morten Damgaard, MD, Ph.D.
Hvidovre Hospital, Copenhagen
- STUDY DIRECTOR
Mustafa Taskiran, MD, Ph.D.
University Hospital Koege
- STUDY DIRECTOR
Viggo B Kristiansen, MD
Glostrup Hospital, Copenhagen
- STUDY DIRECTOR
Knud H Stokholm, MD
University Hospital Koege
- STUDY CHAIR
Niels Gadsboll, MD, DMSc
University Hospital Koege
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 19, 2009
First Posted
October 20, 2009
Study Start
November 1, 2009
Primary Completion
December 1, 2012
Study Completion
January 1, 2013
Last Updated
March 20, 2013
Record last verified: 2013-03